Bayesian Capital Management’s Amdocs DOX Stock Holding History

Bayesian Capital Management’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,300	Closed	-$845K	–	242
2025 Q3	$845K	Buy	+10,300	New	+$893K	0.17%	189
2025 Q2	–	Sell	-11,103	Closed	-$1.02M	–	628
2025 Q1	$1.02M	Buy	+11,103	New	+$969K	0.17%	166
2024 Q1	–	Sell	-5,700	Closed	-$501K	–	854
2023 Q4	$501K	Buy	5,700 +2,100	+58%	+$175K	0.05%	382
2023 Q3	$304K	Buy	+3,600	New	+$325K	0.03%	469
2022 Q2	–	Sell	-6,506	Closed	-$535K	–	849
2022 Q1	$535K	Sell	6,506 -200	-3%	-$15.7K	0.08%	354
2021 Q4	$502K	Buy	6,706 +769	+13%	+$57.7K	0.16%	172
2021 Q3	$449K	Sell	5,937 -2,150	-27%	-$166K	0.13%	203
2021 Q2	$626K	Sell	8,087 -2,663	-25%	-$206K	0.16%	159
2021 Q1	$754K	Buy	+10,750	New	+$812K	0.17%	153
2019 Q4	–	Sell	-14,331	Closed	-$947K	–	629
2019 Q3	$947K	Buy	14,331 +1,100	+8%	+$70.7K	0.18%	156
2019 Q2	$822K	Buy	+13,231	New	+$764K	0.17%	165
2017 Q3	–	Sell	-8,700	Closed	-$561K	–	522
2017 Q2	$561K	Buy	+8,700	New	+$549K	0.21%	166

Other funds holding DOX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Bayesian Capital Management's DOX Position: Q4 2025 in Review

Bayesian Capital Management sold out of Amdocs (DOX) in Q4 2025, closing a stake of 10,300 shares — an estimated $845K sold.

Bayesian Capital Management first reported a position in DOX in Q2 2017 and held it in 12 quarters. The position peaked at $1.02M in Q1 2025. 492 funds tracked by Wall St. Rank hold DOX as of Q4 2025.

Bayesian Capital Management reported no remaining Amdocs position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 10,300 Amdocs shares in Q4 2025, an estimated $845K.
Bayesian Capital Management first reported a position in Amdocs in Q2 2017 and held it in 12 quarters.
Bayesian Capital Management's Amdocs position peaked at $1.02M in Q1 2025.
492 funds tracked by Wall St. Rank held Amdocs as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.